Avantor, Inc. (NYSE:AVTR) Given Consensus Recommendation of “Hold” by Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have received a consensus rating of “Hold” from the eighteen ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $12.4706.

AVTR has been the topic of a number of recent analyst reports. Morgan Stanley increased their target price on Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Barclays boosted their target price on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, June 24th. UBS Group began coverage on shares of Avantor in a report on Wednesday, September 9th. They issued a “neutral” rating and a $16.00 price target on the stock. Jefferies Financial Group raised shares of Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price target on the stock in a research note on Wednesday, July 29th. Finally, Evercore set a $10.50 price objective on shares of Avantor in a research report on Monday, July 6th.

Avantor Trading Up 0.9%

AVTR opened at $15.58 on Friday. The stock has a market cap of $10.54 billion, a price-to-earnings ratio of -18.54, a P/E/G ratio of 11.65 and a beta of 0.89. The stock’s 50 day moving average price is $13.42 and its 200-day moving average price is $10.28. Avantor has a one year low of $7.26 and a one year high of $15.93. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the prior year, the business posted $0.24 earnings per share. The company’s revenue for the quarter was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, equities analysts forecast that Avantor will post 0.81 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Sequoia Financial Advisors LLC raised its position in Avantor by 100.1% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 22,739 shares of the company’s stock valued at $225,000 after purchasing an additional 11,378 shares in the last quarter. Engineers Gate Manager LP grew its position in shares of Avantor by 362.5% during the 2nd quarter. Engineers Gate Manager LP now owns 54,570 shares of the company’s stock worth $540,000 after buying an additional 42,770 shares in the last quarter. Cidel Asset Management Inc. bought a new position in shares of Avantor during the 2nd quarter worth $112,000. Integrated Wealth Concepts LLC purchased a new position in shares of Avantor during the second quarter valued at $128,000. Finally, IFP Advisors Inc increased its stake in shares of Avantor by 901.4% during the second quarter. IFP Advisors Inc now owns 5,858 shares of the company’s stock valued at $58,000 after buying an additional 5,273 shares during the period. Institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc (NYSE: AVTR) is a global provider of products and services used in the life sciences, healthcare and advanced technology industries. The company supports research, drug discovery, biopharmaceutical production, clinical and diagnostic activities, and other laboratory-based applications.

Its offerings include laboratory chemicals and reagents, consumables, equipment, instruments, production materials and related services. Avantor also provides supply-chain, procurement and other technical solutions designed to help customers manage laboratory and manufacturing operations.

Avantor serves customers across pharmaceutical and biopharmaceutical companies, healthcare providers, academic and government institutions, medical laboratories and industrial businesses.